Pre-market Hot Trades in US Stocks
Bloom Energy is up 3.43% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 19, Bloom Energy's stock price rose 3.43% in pre-market trading, mainly driven by its partnership with Oracle. Oracle adopted Bloom's solutions to accelerate the deployment of its AI campus, enhancing market confidence in Bloom's technology. This collaboration and record quarterly performance have made investors optimistic, driving the stock price up.
</li>
<li>
On May 19, Bloom Energy's stock price fell 2.66% during the trading session, influenced by macroeconomic factors. President Trump announced a delay in attacks on Iran, which turned the Dow Jones index positive; however, leading companies in the tech and energy sectors, such as Bloom Energy, still faced selling pressure.
</li>
<li>
On May 18, Bloom Energy's stock price dropped 2.48%, reflecting the market's reaction to its high-flyer signals. Benzinga Edge signals indicated that Bloom Energy's momentum and growth were strong, but its value performance was weak, leading to more severe pullbacks when momentum weakened. The AI industry is growing rapidly, and energy demand is increasing.
</li>
</ol>
ASML is up 3.05% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 17, ASML signed an agreement with Tata Electronics to invest $11 billion in building India's first 300mm wafer fab, focusing on automotive electronics and AI chips. This move highlights India's increasing importance in the global semiconductor supply chain, driving ASML's stock price up. Source: Jinshi Data
</li>
<li>
On May 19, Bloomberg pointed out that chip stocks accounted for a record high proportion in the S&amp;P 500 index in over twenty years, increasing systemic risk due to market concentration. Despite frequent short-term overheating signals, the core logic of long-term growth for AI chips remains unchanged, supporting ASML's stock price. Source: Bloomberg
</li>
<li>
On May 18, Singapore's Department of Statistics announced that non-oil domestic exports in April rose 24.5% year-on-year, with electronic product exports continuing to expand, supported by AI-related demand, indicating strong market demand for semiconductor products. Source: Singapore Department of Statistics, high concentration in the semiconductor industry increases risk.
</li>
</ol>
Top Gainers in Pre-market US Stocks
Silexion is up 151.19% in pre-market trading. Based on recent key news:
<ol>
<li>On May 20, Silexion Therapeutics announced the exercise of warrants, generating total proceeds of $1 million. This news significantly boosted the stock price, as investors expressed optimism about the company's future liquidity and growth prospects. The biotech sector has been active recently.</li>
</ol>
GCL Global is up 82.28% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 19, GCL Global announced a strategic investment from ADATA Technology to accelerate global entertainment and digital growth
This move includes an additional $10 million investment in 4Divinity, significantly boosting the stock price. Source: Reuters
</li>
<li>
On May 19, GCL Global released relevant information through the EDGAR system, further confirming the investment details and enhancing market confidence. Source: Public Technologies
</li>
<li>
On May 20, Benzinga's stock ranking showed that GCL maintained a negative price trend in the short, medium, and long term; nevertheless, investors' positive response to the strategic investment drove the stock price up. Source: Benzinga The market reacted positively to the strategic investment, driving the stock price up.
</li>
</ol>
Jupiter Neurosciences rose 70.72% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 20, Jupiter Neurosciences obtained exclusive U.S. rights to ALA-002 from PharmAla Biotech, valued at $100 million. This deal positions the company at the forefront of developing next-generation MDMA therapies, significantly boosting the stock price. Source: GlobeNewswire
</li>
<li>
On May 20, President Trump's executive order accelerated progress in the field of psychedelics, making Jupiter Neurosciences likely to achieve significant breakthroughs in this area, further stimulating the stock price increase. Source: GlobeNewswire
</li>
<li>
On May 20, Jupiter Neurosciences' strategic initiatives solidified its position in the MDMA therapy field, and the market is confident about its future development, resulting in a substantial rise in stock price. Source: GlobeNewswire Policy support for the psychedelics field has strengthened, and the market is active
</li>
</ol>

ASML

Bloom Energy pre-market up 3.43%; ASML pre-market up 3.05%; Silexion Therapeutics pre-market up 151.19%; GCL Global pre-market up 82.28%; Jupiter Neurosciences pre-market up 70.72%

Price Alert

Pre-market hot trades in US stocks: Bloom Energy up 3.43% in pre-market; ASML up 3.05% in pre-market